River Front Investment Group, LLC Amgen Inc Transaction History

River Front Investment Group, LLC

  • $4.15 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 02, 2021
SELL
$212.27 - $248.7 $224,369 - $262,875
-1,057 Closed
0 $0
Q2 2021

Aug 09, 2021
BUY
$233.58 - $259.14 $8,876 - $9,847
38 Added 3.73%
1,057 $258,000
Q1 2021

Apr 29, 2021
BUY
$221.91 - $258.6 $226,126 - $263,513
1,019 New
1,019 $253,000

Others Institutions Holding AMGN

# of Institutions
3,122
Shares Held
409M
Call Options Held
7.56M
Put Options Held
7.2M
View Full List

About AMGEN INC

AMGN Quotes by TradingView
  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $149B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track River Front Investment Group, LLC Portfolio

Follow River Front Investment Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of River Front Investment Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on River Front Investment Group, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email